Kronos Bio, Inc. Operating Income
Kronos Bio, Inc. reported Operating Income of -$9.44 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-05-08
- Kronos Bio, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$9.44M.
- Kronos Bio, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$27.15M.
- Kronos Bio, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$15.72M.
- Kronos Bio, Inc. operating income (loss) for the quarter ending 2024-06-30 was -$18.02M.
- Kronos Bio, Inc. operating income (loss) for fiscal 2024 was -$92.89M.
- Kronos Bio, Inc. operating income (loss) for fiscal 2023 was -$122.08M.
- Kronos Bio, Inc. operating income (loss) for fiscal 2022 was -$137.12M.
- Kronos Bio, Inc. operating income (loss) for fiscal 2021 was -$151.40M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | -$9.44M 10-Q · filed 2025-05-08 | -$36.60M derived: sum of 2 quarters · filed 2025-05-08 | -$52.31M derived: sum of 3 quarters · filed 2025-05-08 | -$70.33M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-12-31 | -$27.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$42.87M derived: sum of 2 quarters · filed 2025-03-18 | -$60.89M derived: sum of 3 quarters · filed 2025-03-18 | -$92.89M 10-K · filed 2025-03-18 | |
| 2024-09-30 | -$15.72M 10-Q · filed 2024-11-13 | -$33.74M derived: sum of 2 quarters · filed 2024-11-13 | -$65.73M 10-Q · filed 2024-11-13 | -$93.32M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-06-30 | -$18.02M 10-Q · filed 2024-08-08 | -$50.02M 10-Q · filed 2024-08-08 | -$77.61M derived: sum of 3 quarters · filed 2025-05-08 | -$111.43M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-03-31 | -$31.99M 10-Q · filed 2025-05-08 | -$59.59M derived: sum of 2 quarters · filed 2025-05-08 | -$93.41M derived: sum of 3 quarters · filed 2025-05-08 | -$125.58M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$27.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$61.42M derived: sum of 2 quarters · filed 2025-03-18 | -$93.58M derived: sum of 3 quarters · filed 2025-03-18 | -$122.08M 10-K · filed 2025-03-18 | -$121.83M 10-K · filed 2024-03-21 |
| 2023-09-30 | -$33.83M 10-Q · filed 2024-11-13 | -$65.99M derived: sum of 2 quarters · filed 2024-11-13 | -$94.49M 10-Q · filed 2024-11-13 | -$128.17M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$32.17M 10-Q · filed 2024-08-08 | -$60.66M 10-Q · filed 2024-08-08 | -$94.34M derived: sum of 3 quarters · filed 2024-08-08 | -$127.88M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$28.49M 10-Q · filed 2024-05-09 | -$62.17M derived: sum of 2 quarters · filed 2024-05-09 | -$95.71M derived: sum of 3 quarters · filed 2024-05-09 | -$129.24M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$33.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$67.22M derived: sum of 2 quarters · filed 2024-03-21 | -$100.75M derived: sum of 3 quarters · filed 2024-03-21 | -$137.12M 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$33.54M 10-Q · filed 2023-11-13 | -$67.07M derived: sum of 2 quarters · filed 2023-11-13 | -$103.43M 10-Q · filed 2023-11-13 | -$165.84M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$33.53M 10-Q · filed 2023-08-08 | -$69.89M 10-Q · filed 2023-08-08 | -$132.30M derived: sum of 3 quarters · filed 2023-08-08 | -$165.97M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$36.37M 10-Q · filed 2023-05-10 | -$98.77M derived: sum of 2 quarters · filed 2023-05-10 | -$132.44M derived: sum of 3 quarters · filed 2023-05-10 | -$161.59M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$62.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$96.08M derived: sum of 2 quarters · filed 2023-03-15 | -$125.22M derived: sum of 3 quarters · filed 2023-03-15 | -$151.40M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$33.67M 10-Q · filed 2022-11-08 | -$62.81M derived: sum of 2 quarters · filed 2022-11-08 | -$88.99M 10-Q · filed 2022-11-08 | -$110.08M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | -$29.14M 10-Q · filed 2022-08-04 | -$55.32M 10-Q · filed 2022-08-04 | -$76.41M derived: sum of 3 quarters · filed 2022-08-04 | -$97.22M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | -$26.18M 10-Q · filed 2022-05-04 | -$47.27M derived: sum of 2 quarters · filed 2022-05-04 | -$68.08M derived: sum of 3 quarters · filed 2022-05-04 | -$76.87M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | -$21.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$41.90M derived: sum of 2 quarters · filed 2022-02-24 | -$50.70M derived: sum of 3 quarters · filed 2022-02-24 | -$58.04M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$20.81M 10-Q · filed 2021-11-09 | -$29.61M derived: sum of 2 quarters · filed 2021-11-09 | -$36.96M 10-Q · filed 2021-11-09 | -$42.81M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$8.80M 10-Q · filed 2021-08-12 | -$16.15M 10-Q · filed 2021-08-12 | -$22.00M derived: sum of 3 quarters · filed 2022-02-24 | -$26.33M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$7.35M 10-Q · filed 2021-05-11 | -$13.21M derived: sum of 2 quarters · filed 2022-02-24 | -$17.53M derived: sum of 3 quarters · filed 2022-02-24 | ||
| 2019-12-31 | -$5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$10.18M derived: sum of 2 quarters · filed 2022-02-24 | -$16.82M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$4.32M 10-Q · filed 2020-11-18 | -$10.96M 10-Q · filed 2020-11-18 | |||
| 2018-12-31 | -$6.64M 10-K · filed 2021-03-23 |